Insider Buying Signals a Quiet Confidence in LiveRamp’s Future The latest director‑dealing filing from CHOW Vivian shows a purchase of 1,039 shares on May 15, 2026—an event that, on its own, represents a modest 3.4 % increase in her holdings (from 29,166 to 30,205 shares). The shares were granted as part of her compensation for serving on the board, rather than a market‑based trade. Nonetheless, the fact that a director is receiving new shares at the current price of $37.68—well above the $21.71 low of the year and just shy of the 52‑week high—underscores the board’s confidence in the company’s valuation trajectory.

Investor Takeaway: A Steady Hand in a Volatile Landscape LiveRamp’s share price has surged more than 30 % in the past week and nearly 35 % year‑to‑date, driven in large part by the announced acquisition by Publicis. In that context, the issuance of director‑compensated shares can be read as a vote of confidence from senior governance, mitigating concerns that the acquisition price may be a bubble. For investors, the move suggests that the board believes the strategic fit will unlock additional value—especially as LiveRamp’s data‑activation platform is positioned to power AI‑driven marketing solutions for Publicis’s client base.

A Broader Insider Activity Snapshot While CHOW’s transaction is a buy, the company‑wide filing shows a handful of other insiders (Timothy R. Cadogan, John L. Battelle, and Kristi Argyilan) each acquiring 1,039 to 1,234 shares on the same day. In contrast, several senior executives—including Chief Revenue Officer Sharma Vihan and Chief Technology Officer Hussain Mohsin—have recently sold sizable blocks (up to 5,977 shares) as part of compensation or personal portfolio rebalancing. This mixed pattern—buying by board members, selling by executives—may indicate that leadership is hedging personal positions while still betting on the long‑term upside of the company’s platform and the Publicis deal.

Profile of CHOW Vivian CHOW’s insider history is sparse but consistent. Her first recorded purchase was 1,723 shares on February 11, 2026, raising her stake to 29,166 shares. The recent May 15 trade is another board‑compensation grant, bringing her holdings to 30,205 shares. No sales have been recorded, suggesting she is not divesting but rather accumulating a stake that reflects her confidence in LiveRamp’s strategic direction. Her holding level—just over 30 k shares—places her among the moderate‑size insiders, and the fact that her purchases are all compensation‑based may signal a long‑term commitment to the company’s success rather than a speculative play.

Implications for the Company’s Future With the Publicis acquisition looming, LiveRamp’s board and senior directors appear to be positioning themselves for a smooth transition while safeguarding their own equity positions. The pattern of compensation‑based share grants amid a recent surge in share price and a high buzz level (300 % social‑media intensity) suggests that insiders believe the market has not yet fully priced in the upside potential of the deal. For investors, this insider confidence—coupled with the strategic rationale behind the acquisition—could serve as a bullish sign, reinforcing the view that LiveRamp is well‑placed to capitalize on the growing demand for AI‑enabled marketing platforms.

DateOwnerTransaction TypeSharesPrice per ShareSecurity
2026-05-15CHOW VIVIAN ()Buy1,039.00N/ACOMMON STOCK, $.10 PAR VALUE
2026-05-15CADOGAN TIMOTHY R. ()Buy1,039.00N/ACOMMON STOCK, $.10 PAR VALUE
2026-05-15BATTELLE JOHN L. ()Buy1,234.00N/ACOMMON STOCK, $.10 PAR VALUE
2026-05-15Argyilan Kristi ()Buy1,039.00N/ACOMMON STOCK, $.10 PAR VALUE